Maksymilian Prondzynski, Raul H Bortolin, Paul Berkson, Michael A Trembley, Kevin Shani, Mason E Sweat, Joshua Mayourian, Albert M Cordoves, Nnaemeka J Anyanwu, Yashasvi Tharani, Justin Cotton, Joseph B Milosh, David Walker, Yan Zhang, Fujian Liu, Xujie Liu, Kevin K Parker, Vassilios J Bezzerides, William T Pu
In the last decade human iPSC-derived cardiomyocytes (hiPSC-CMs) proved to be valuable for cardiac disease modeling and cardiac regeneration, yet challenges with scale, quality, inter-batch consistency, and cryopreservation remain, reducing experimental reproducibility and limiting clinical translation. Here, we report a robust cardiac differentiation protocol that uses Wnt modulation and a stirred suspension bioreactor to produce on average 124 million hiPSC-CMs with >90% purity using a variety of hiPSC lines (19 differentiations; 10 iPSC lines)...
February 28, 2024: bioRxiv